Clinical Trials Logo

Clinical Trial Summary

To evaluate the effectiveness and safety of compound probiotic in shortening the course of illness in children with viral pneumonia, in comparison with placebo.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06348095
Study type Interventional
Source Wecare Probiotics Co., Ltd.
Contact
Status Not yet recruiting
Phase N/A
Start date May 7, 2024
Completion date December 31, 2024

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05286255 - Mesenchymal Stromal Cells for COVID-19 and Viral Pneumonias Phase 1
Recruiting NCT04952337 - Clinical, Molecular and Functional Biomarkers for PROgnosis, Pathomechanisms and Treatment Strategies of COVID-19 (PROVID) - (PROVID-CAPNETZ)
Completed NCT04606407 - Inhaled NO for the Treatment of Viral Pneumonia in Adults N/A
Not yet recruiting NCT05612893 - Discover the Immune Signature of Sepsis Caused by Acute Pulmonary Infection: A Cohort Study
Not yet recruiting NCT04397497 - Mavrilimumab in Severe COVID-19 Pneumonia and Hyper-inflammation (COMBAT-19) Phase 2
Terminated NCT04345289 - Efficacy and Safety of Novel Treatment Options for Adults With COVID-19 Pneumonia Phase 3
Enrolling by invitation NCT04326036 - Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 Infection Early Phase 1
Withdrawn NCT00645619 - Use of TREM-1 Protein to Differentiate Viral and Bacterial Pneumonias in Intubated Children
Completed NCT04385823 - Use of High Flow Nasal Cannula Oxygen and Covid-19 Acute Hypoxemic Respiratory Failure
Not yet recruiting NCT04876573 - Pilot Study for Cyproheptadine in Hospitalized Patient for COVID-19 Phase 2
Unknown status NCT01612572 - A Registry Study on Xiyanping(a Chinese Medicine Injection) Used in Fifty Hospitals N/A
Completed NCT02152358 - PTH - Preemptive Treatment for Herpesviridae Phase 4
Completed NCT04644302 - Circulatory Coherence in COVID-19 and Non-COVID-19 Patients With Sepsis
Recruiting NCT05531149 - Efficacy and Safety of Trimodulin (BT588) in Subjects With CAP Including COVID-19 Pneumonia Phase 3
Not yet recruiting NCT04955223 - Yinhu Qingwen Granule in the Treatment of Viral Pneumonia Early Phase 1
Completed NCT01868113 - Inhaled Corticosteroids in U-5 Children With Acute Respiratory Infection in Uganda: A Randomised Trial Phase 3
Recruiting NCT04380376 - Low-doses Melphalan Inhalation in Patients With COVID-19 (CoronavIrus Disease 2019) Pneumonia Phase 2
Completed NCT05386459 - Study of the Use of the Drug Ingaron in Patients With COVID-19
Not yet recruiting NCT06349707 - Multiplex PCR for Severe Respiratory Infections During the COVID-19 Pandemic
Completed NCT04394026 - Imaging Feature of SARS-CoV2 Infection